OR WAIT null SECS
Millipore has acquired European-based services provider BioAnaLab, extending the company&39;s biopharmaceutical services business into Europe.
Millipore has acquired European-based services provider BioAnaLab, extending the company's biopharmaceutical services business into Europe.
"Our acquisition of BioAnaLab will allow us to build on our reputation as a trusted outsource partner in North America by establishing a presence in the fast-growing European biotech market," said Jonathan DiVincenzo, president of the company’s bioscience division, in a statement. "BioAnaLab will add cGMP support testing capabilities to our portfolio, a solid customer base and a team of services professionals with expertise in emerging scientific disciplines."
BioAnaLab current offerings include assay transfer/development, validation and sample analysis and vaccine services. Millipore's experience in biomarker analytical services is expected to strengthen BioAnaLab's current offerings in that area.